Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Polymorphisms in Genes Involved in Folate Metabolism and Plasma DNA Methylation in Colorectal Cancer Patients

Oncology Reports
MedicineCancer ResearchOncology
2010English

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy

Cancers
Cancer ResearchOncology
2020English

Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2007English

Polymorphisms in the Genes Involved in the Arachidonic Acid-Pathway, Fish Consumption and the Risk of Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2006English

Targeting Nuclear EGFR: Strategies for Improving Cetuximab Therapy in Lung Cancer

2013English

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Identification of Key Genes and Pathways Involved in Microsatellite Instability in Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

PTEN Status in Advanced Colorectal Cancer Treated With Cetuximab

British Journal of Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy